SCIENCE CHINA Life Sciences, Volume 59 , Issue 4 : 398-399(2016) https://doi.org/10.1007/s11427-016-5045-2

Profile of Xiyun Yan

  • AcceptedMar 5, 2016
  • PublishedApr 5, 2016


There is no abstract available for this article.


[1] Lasek, W., Zagozdzon, R., and Jakobisiak, M. (2014). Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother 63, 419-435.. Google Scholar

[2] Duan, D., Fan, K., Zhang, D., Tan, S., Liang, M., Liu, Y., Zhang, J., Zhang, P., Liu, W., Qiu, X., Kobinger, G., Gao, G., and Yan, X.(2015).Nanozyme-strip for rapid local diagnosis of Ebola. Biosens Bioelectron 74, 134-141. Google Scholar

[3] Fan, K., Cao, C., Pan, Y., Lu, D., Yang, D., Feng, J., Song, L., Liang, M., and Yan, X.(2012). Magnetoferritin nanoparticles for targeting and visualizing tumor tissues. Nat Nanotechnol 7, 459-464. Google Scholar

[4] Gao, L., Z, J., Nie, L., Zhang, J., Zhang, Yu., Gu, N., Wang, T., Feng, J., Yang, D., Perrett, S., and Yan, X.(2007). Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nat Nanotechnol 2, 577-583. Google Scholar

[5] Jiang, T., Zhuang, J., Duan, H., Luo, Y., Zeng, Q., Fan, K., Yan, H., Lu, D., Ye, Z., Hao, J., Feng, J., Yang, D., and Yan, X.(2012). CD146 is a co-receptor for VEGFR-2 in tumor angiogenesis. Blood 120, 2330-2339. Google Scholar

[6] Liang, M., Fan, K., Zhou, M., Duan, D., Zheng, J., Yang, D., Feng, J., and Yan, X.(2014). H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection. Proc Natl Acad Sci USA 111, 14900-14905. Google Scholar

[7] Luo, Y., Zheng, C., Zhang, J., Lu, D., Zhuang, J., Xing, S., Feng, J., Yang,D., and Yan, X.(2012). Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migration. Oncogene 31, 306-321. Google Scholar

[8] Tu, T., Zhang, C., Yan, H., Luo, Y., Kong, R., Wen, P., Ye, Z., Chen, J., Feng, J., Liu, F., Wu, J., and Yan, X.(2015). CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development.Cell Res 25, 275-287. Google Scholar

[9] Yan, X., Lin, Y., Yang, D., Shen, Y., Yuan, M., Zhang, Z., Li, P., Xia, H., Li, L., Luo, D., Liu, Q., Mann, K., and Bader, B.(2003) A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 102, 184-191. Google Scholar

[10] Ye, Z., Zhang, C., Tu, T., Sun, M., Liu, D., Lu, D., Feng, J., Yang, D., Liu, F., and Yan, X.(2013). Wnt5a uses CD146 as a receptor to regulate cell motility and convergent extension. Nature Commun 4, 2803. Google Scholar

[11] Zeng, Q., Li, W., Lu, D., Wu, Z., Duan, H., Luo, Y., Feng, J., Yang, D., Fu, L., and Yan, X.(2012). CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc Natl Acad Sci USA 109, 1127-1132. Google Scholar

Copyright 2020 Science China Press Co., Ltd. 《中国科学》杂志社有限责任公司 版权所有

京ICP备17057255号       京公网安备11010102003388号